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 NEWS NEWS & ViEWS
The family Herpesviridae is a large, diverse 
family of double-stranded enveloped DNA 
viruses. Herpes B virus (BV) and Cercopithecine 
herpesvirus 2 (CeHV-2) are simian herpesvi-
ruses. Like herpes simplex virus 1 (HSV-1), they 
belong to the a-herpesvirus subfamily. interest 
in BV infections results from the observation 
that zoonotic infections often result in death 
of humans, whereas infection of macaques, 
the natural host of BV, results in disease similar 
to that observed on HSV infections of humans. 
We recently reported in cell-cell fusion assays 
in which nectin-1, a HSV-1 gD receptor, medi-
ated fusion of cells expressing glycoproteins 
from both BV and CeHV-2. However, HVEM, 
another HSV-1 gD receptor, did not medi-
ate fusion by BV and CeHV-2 glycoproteins. 
Paired immunoglobulin-like type 2 receptor a 
(PiLRa), an HSV-1 gB fusion receptor, did not 
mediate fusion with BV or CeHV-2 glycopro-
teins. These results were further confirmed by 
BV infection. Our results may indicate that dif-
ferential receptor usage by BV in humans when 
compared with macaques may have patho-
logical consequences. Understanding human 
and simian receptor usage for BV and HSV may 
provide clues to understand the pathogenesis 
of these viruses, as well as related viruses, in 
their natural host as well zoonotic infections. 
This broader understanding may result in the 
development of novel therapeutics to control 
deadly BV infections as well as herpesvirus 
infections in general.
Herpes B virus (BV, officially named as 
Macacine herpesvirus 1, formerly Herpesvirus 
simiae, monkey B virus, or Cercopithecine her-
pesvirus 1) and Cercopithecine herpesvirus 2 
(CeHV-2, formerly simian agent 8) are primate 
herpesviruses belonging to the a-herpesvirus 
subfamily and are closely related to herpes 
simplex virus 1 (HSV-1) and HSV-2. HSV causes 
recurrent mucocutaneous lesions on the 
mouth, face, or genitalia and in rare cases can 
cause meningitis or encephalitis. BV naturally 
infects macaques whereas zoonotic infections 
of foreign hosts, such as humans, can result 
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in encephalitis, encephalomyelitis and death. 
BV infection has high mortality in humans 
(greater than 50% in documented infections) 
and as such is recognized as a deadly virus for 
humans requiring biosafety level 4. Similarly 
to the high level of pathogenicity of BV in 
humans, HSV infection of marmosets can also 
be fatal. CeHV-2 is a pathogen of baboons and 
is not known to cause disease in primates out-
side the natural hosts. Since the receptors for 
HSV are well described, we chose to explore 
the receptor usage of the BV and CeHV-2.
HSV entry into target cells requires a mini-
mum four virus encoded glycoproteins—gly-
coproteins B (gB), D (gD), H (gH) and L (gL). 
These glycoproteins interact with a variety 
of cellular receptors to facilitate virus entry. 
Best described are the cellular receptors 
for gB and gD which we chose to study. 
The interaction of gD with the gD recep-
tors has been extensively investigated. The 
binding of gD to herpesvirus entry mediator 
(HVEM) (Montgomery et al., Cell 1996), nec-
tin-1 (Geraghty et al., Science 1998), nectin-2 
(Warner et al., Virology 1998) and modified 
heparan sulfate (Shukla et al., Cell 1999) trig-
gers fusion of the virion envelope with a cel-
lular membrane. Paired immunoglobulin-like 
type 2 receptor a (PiLRa) is a receptor that 
binds to gB and also mediates entry and 
fusion (Satoh et al., Cell 2008) even though 
it shows much less fusion activity than the 
gD receptors nectin-1 and HVEM. Two other 
gB receptors, with less known in regard to 
the significance in virus infection, are myelin-
associated glycoprotein (MAG) (Suenaga 
et al., Proc Natl Acad Sci U S A 2010), and non-
muscle myosin heavy chain iiA (NMHC-iiA) 
(Arii et al., Nature 2010). HVEM is a member 
of the tumor necrosis factor receptor family. 
Nectin-1 and nectin-2 are cell adhesion mol-
ecules in the immunoglobulin superfamily 
and are widely expressed by a variety of cell 
types, including epithelial cells and neurons. 
Specific sites in heparan sulfate generated by 
certain 3-O-sulfotransferases (3-O-S HS) can 
also serve as a gD-binding entry receptor. 
PiLRa is expressed on cells of the immune sys-
tem. MAG is a cell-surface molecule belonging 
to immunoglobulin superfamily, is usually 
expressed in neural tissues. NMHC-iiA not 
only functions in the cytoplasm but also func-
tions on the cell surface with gB upon viral 
entry. NMHC-iiA is expressed in a broad range 
of cell lines, tissues and cell types in vivo.
To begin our studies, we generated expres-
sion constructs for the homologous glyco-
proteins (gB, gD, gH and gL) necessary for 
HSV-1 fusion from BV and CeHV-2. We then 
performed cell-cell fusion assays to determine 
which cellular and viral proteins were required 
for cell-cell fusion. The results indicated that 
nectin-1 is the primary receptor that mediates 
fusion for BV and CeHV-2, and that HVEM and 
PiLRa do not function for BV and CeHV-2. To 
verify our cell-cell fusion results, we used cells 
expressing human nectin-1, HVEM or PiLRa 
and determined if they could be infected with 
BV. The results confirmed that BV only utilizes 
nectin-1 and not HVEM or PiLRa. To confirm 
that BV and CeHV-2 do not utilize human 
HVEM as an entry receptor because of differ-
ences between human and simian HVEM, we 
performed cell-cell fusion assays with sim-
ian HVEM. in these experiments, we found 
that simian HVEM could mediate fusion with 
cells expressing HSV-1 glycoproteins however; 
simian HVEM did not mediate fusion of cells 
expressing glycoproteins from BV and CeHV-2. 
Thus, as found in earlier studies and reports 
from other investigators, our findings are com-
patible with the idea that nectin-1 is a pan 
a-herpesvirus entry receptor.
Of particular interest from our recent stud-
ies is the idea that differential receptor usage 
may be important for pathogenesis in infected 
hosts. Compatible with this idea, studies in 
mice have shown that nectin-1 is the primary 
receptor responsible for the infection of the 
vaginal epithelium with HSV-2. interestingly, 
in experimental vaginal infections, nectin-1 
was not the sole receptor capable of enabling 
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spread of HSV infection from the vaginal epi-
thelium to the PNS and CNS (Taylor et al., Cell 
Host and Microbe 2007). However, expression 
of nectin-1 is necessary for HSV-2 infection 
via the intracranial route and for encephalitis 
while HVEM was not important (Kopp et al., 
Proc Natl Acad Sci U S A 2009). in contrast, in 
HSV-1 infection of the murine eye, we found 
that both HVEM and nectin-1 must be pres-
ent for maximal HSV-1 infection further sug-
gesting that receptor requirements for HSV 
depends on the route of infection and/or sero-
type (Karaba et al., J Virol 2011). The host 
immune response may also be important in 
pathogenesis. Previous studies have shown 
that engagement of HVEM by gD alters the 
immune response following murine vaginal 
infection. in these studies, there was a tran-
sient increase in mucosal chemokine and iL-6 
levels when compared with infection with 
wild-type control virus in agreement with gD-
HVEM interaction elicits an innate response 
(Yoon et al., PloS One 2011). Overall, our stud-
ies, as well as studies by others, indicate that 
choice of receptor utilized as well as the host 
may be important determinants in regard to 
the outcome of the infection. Virus receptor 
usage, replication and control by the host 
immune are likely fine-tuned to allow maximal 
virus replication without being detrimental 
to the host to allow virus spread to naive 
hosts. in contrast, when a virus infects a non-
natural host, this balance may not exist result-
ing in severe pathogenesis as observed in BV 
infections of humans. By understanding the 
required interactions between host receptors 
and the relevant glycoproteins required for 
infection, novel therapeutics might be devel-
oped to treat zoonotic infections and prevent 
deadly infections or more broadly used in 
natural HSV infections that routinely occur 
within the human population.
Homologs of the Bacillus subtilis DiviVA protein 
can be found in a wide variety of Gram-positive 
bacteria. DiviVA proteins are coiled-coil pro-
teins that bind to the cytosolic face of the 
cytoplasmic membrane and accumulate at 
membrane regions with higher curvature. By 
directly interacting with downstream proteins 
they serve as spatial regulators of other cel-
lular processes. initial DiviVA studies focused 
on its role as a topological determinant for the 
MinCDJ division inhibiting complex in B. sub-
tilis, but recent evidence suggests that DiviVA 
can fulfill more diverse roles in different spe-
cies of the firmicutes and actinomycetes and 
can even be relevant for virulence.
DiviVA proteins are highly conserved 
among different Gram-positive bacteria. They 
are lipid binding proteins sensitive to mem-
brane curvature and accumulate at areas of 
the cytoplasmic membrane that are more 
strongly bent (concave) (Lenarcic et al., EMBO 
J 2009; Ramamurthi and Losick, Proc Natl 
Acad Sci U S A 2009). Zones with higher 
membrane curvature occur at the cell poles of 
non-coccoid bacteria and establish along the 
invaginating membrane ring at the site of cell 
division. DiviVA orthologs of different bacteria 
were shown to localize to these subcellular 
regions even when expressed heterologously 
in other taxa suggesting that membrane bind-
ing and curvature sensitivity is an intrinsic 
feature of DiviVA and does not require the 
assistance of other factors (Edwards et al., 
EMBO J 2000). As an autonomously localizing 
protein, DiviVA acts as a topological determi-
nant for different cellular processes. DiviVA of 
Bacillus subtilis functions as a spatial regula-
tor of the FtsZ-inhibiting MinCD proteins and 
restricts their activity to the polar and septal 
regions of the cell, preventing division in the 
chromosome-free spaces near the poles and in 
the vicinity of an existing Z-ring (Marston et al., 
Genes Dev 1998; Fig. 1A). During sporulation 
of B. subtilis, however, polar localized DiviVA 
tethers the origin region of the spore chromo-
some to the distal pole of the prespore. This 
polar origin recruitment is vital for the correct 
transfer of one chromosome copy from the 
mother cell into the developing spore com-
partment and is thus essential for sporulation 
(Thomaides et al., Genes Dev 2001; Fig. 1A). 
Both functions involve direct protein-protein 
interactions of DiviVA to specific binding part-
ners: The trans-membrane protein MinJ is 
the molecular bridge mediating the contact 
between DiviVA and MinD to ensure polar and 
septal recruitment of MinCD (Bramkamp et al., 
Mol Microbiol 2008; Patrick and Kearns, Mol 
Microbiol 2008), whereas RacA acts as a sporu-
lation specific DiviVA binding partner (Ben-
Yehuda et al., Science 2003; Wu and Errington, 
Mol Microbiol 2003). This protein binds to 
14 bp inverted repeats scattered around the 
chromosomal origin and also binds directly 
to DiviVA (Ben-Yehuda et al., Mol Cell 2005; 
Lenarcic et al., EMBO J 2009).
in a recent study (Halbedel et al., Mol 
Microbiol 2012) we have analyzed the func-
tion of DiviVA in the facultative human patho-
gen Listeria monocytogenes, which is closely 
related to B. subtilis. To our surprise, deletion of 
the divIVA gene in L. monocytogenes caused a 
phenotype that was different from the classical 
filamentous and mini-cell producing pheno-
type of a B. subtilis DdivIVA mutant. in contrast, 
DdivIVA mutants of L. monocytogenes grew 
as long chains of cells that had clearly com-
pleted cell division, which however remained 
attached even after completion of cross wall 
synthesis. Electron microscopy revealed that 
the daughter cell cytoplasms of the DdivIVA 
mutant were precisely separated at the divi-
sion site and a cross wall was made in-between 
them. But whereas wild-type cells degrade this 
cross wall to physically separate the daughter 
cells, cross walls of the DdivIVA mutant showed 
no signs of degradation. Obviously, deletion of 
divIVA had affected the post-divisional sepa-
ration of daughter cells and not cell division 
per se. Since L. monocytogenes encodes two 
autolysins, p60 and MurA, that play a role in 
cross wall turnover (Pilgrim et al., infect immun 
2003; Carroll et al., J Bacteriol 2003), we tested 
their production in the DdivIVA background. 
We found that secretion of p60 and MurA 
was severely impaired in DdivIVA cells and 
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this result led us to the acces-
sory secretion ATPase SecA2. 
Accessory SecA2 ATPases are 
encoded by a number of Gram-
positive pathogens in addition to 
the canonical housekeeping SecA 
and specifically help to translo-
cate a small subset of secretory 
proteins across the cytoplasmic 
membrane. Both listerial autoly-
sins are known substrates of this 
secretion route (Lenz et al., Proc 
Natl Acad Sci U S A 2003) and 
therefore it appeared plausible 
that DiviVA somehow is involved 
in this. We tested this concept by 
comparing the secretion defect 
of the DsecA2 deletion strain with 
the DdivIVA mutant. And indeed, 
both mutants were similarly defi-
cient in p60 and MurA secretion 
and accumulated the precursors 
of p60 and MurA inside their 
cytoplasms to the same extent. A 
microscopic analysis of the sub-
cellular localization of p60, MurA 
and SecA2 gave us the first hint 
as to how DiviVA might act at 
the molecular level. GFP-tagged 
versions of p60, MurA and SecA2 
localized to the division sites, 
suggesting that SecA2-dependent secretion 
of p60 and MurA occurs at the septum. in a 
DdivIVA mutant however, p60-GFP and MurA-
GFP are diffuse whereas the subcellular distri-
bution of SecA2 was unaffected. One possible 
interpretation is that DiviVA might recruit the 
pre-proteins of p60 and MurA to the invaginat-
ing membrane ring that occurs at the division 
site as soon as the divisome starts to constrict 
(Fig. 1B). Septal autolysin secretion might be 
one mechanism to restrict the activity of p60 
and MurA to the freshly synthesized cross wall 
peptidoglycan that is the substrate of both 
autolysins. Cells lacking DiviVA fail to target 
the secretion substrates to the translocon, 
hence secretion of autolysins cannot occur. 
This role of DiviVA in SecA2-dependent autoly-
sin secretion had pleiotropic implications for 
the biology of L. monocytogenes: likewise to 
naturally occurring secA2 mutants or dele-
tion mutants in secA2 (Lenz and Portnoy, Mol 
Microbiol 2002), DdivIVA cells formed rough 
colonies. They cannot grow as a biofilm and 
were non-motile even though flagella were 
clearly assembled on the cell surface. in vitro 
infection models revealed that DdivIVA cells 
were severely attenuated in terms of invasion 
and cell-to-cell spread and the severity of 
these effects was similar to those seen with a 
DsecA2 mutant strain. Most likely, the forma-
tion of long cell chains impairs the ability of 
L. monocytogenes to enter eukaryotic host cells 
and prevents coordinated intracellular motility 
and thus bacterial spreading in host tissues.
These data already indicated that the func-
tion of DiviVA proteins might be quite diverse 
even in closely related species. However, 
another recent publication (Donovan et al., 
Mol Microbiol 2012) further illustrates the 
diversity of DiviVA functions. in the actino-
mycete Corynebacterium glutamicum, DiviVA 
is supposed to act as a polar origin tether-
ing factor during chromosome segregation 
(Fig. 1C). This was deduced from experiments 
where DiviVA and the centromere-binding 
protein ParB were expressed as fluorescently 
tagged versions in Escherichia coli. Polar and 
septal localization of ParB-CFP clearly required 
the presence of DiviVA in the heterologous 
E. coli background. ParB binds to 16 bp direct 
repeats, called parS sites, near the origin of the 
C. glutamicum chromosome, and was found to 
accumulate close to the cell poles in C. glutam-
icum cells (Donovan et al., J Bacteriol 2010). 
The divIVA gene could not be deleted from the 
C. glutamicum genome suggesting that it 
codes for an essential cellular function (Ramos 
et al., Microbiology 2003) but depletion of 
DiviVA resulted in coccoid cells, which normally 
would grew as rods (Letek et al., J Bacteriol 
2008). Whether polar localization of ParB is lost 
and chromosomes are less efficiently segre-
gated under this condition has so far not been 
addressed experimentally. But expression of 
a mutant ParB protein that no longer binds 
to DiviVA (ParBR21A) in cells of C. glutamicum 
resulted in a clear chromosome segregation 
defect as many anucleate cells were produced. 
in line with these results, ParBR21A fused to 
CFP was less frequently recruited to the cell 
poles (Donovan et al., Mol Microbiol 2012). 
Taken together these data support a model in 
which polar localized DiviVA is used to attach 
the chromosomal origins to the cell pole via 
the centromere-binding protein ParB and this 
Figure 1. Models illustrating the diverse DiviVA functions in different Gram-positive bacteria. (A) B. subtilis 
DiviVA recruits the Z-ring inhibitors MinCDJ away from mid-cell in order to ensure Z-ring formation in the 
chromosome free space at mid-cell. During sporulation the prespore chromosome is tethered to the prespore 
pole via RacA which binds to polar DiviVA. (B) L. monocytogenes DiviVA is required for efficient protein secretion 
via the accessory secretion ATPase SecA2. DiviVA recruits the autolysins p60 and MurA to the division septum 
from where they are secreted in a SecA2-dependent manner. Please note that septal localization of SecA2 is 
independent of DiviVA. (C) in different actinobacteria, DiviVA marks the site of cell wall synthesis at the poles 
and the hyphal tips indicating that DiviVA recruits cell wall biosynthetic proteins to these subcellular regions. 
DiviVA of several actinobacteria furthermore interacts with ParB, an origin binding protein, in order to recruit 
the origin to the cell poles. it is believed that this event is required for efficient chromosome segregation.
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event facilitates chromosome segregation in 
C. glutamicum (Fig. 1C). The same study pro-
vided evidence for similar interactions between 
the DiviVA homolog of Mycobacterium tuber-
culosis Wag31 and its cognate ParB protein, 
as well as between DiviVA and ParB from 
Streptomyces coelicolor (Donovan et al., Mol 
Microbiol 2012). Hence, the role of DiviVA in 
polar recruitment of ParB likely represents a 
conserved feature of the actinobacteria.
Morphological aberrations upon DiviVA 
depletion are also seen in other actinobacteria 
in which the divIVA gene is essential such as 
S. coelicolor and Mycobacterium smegmatis. 
The reason for this is that cell growth in acti-
nobacteria is brought about by polar cell wall 
elongation, which is mediated by the DiviVA-
dependent recruitment of the peptidoglycan 
biosynthetic apparatus to the poles of the 
cell (Flärdh, Mol Microbiol 2003; Kang et al., 
Microbiology 2008; Letek et al., J Bacteriol 
2008; Hempel et al., J Bacteriol 2008). it is 
presently unknown which exact peptidogly-
can biosynthetic proteins are recruited to the 
cell poles by actinobacterial DiviVA proteins. 
However, two emerging candidates are the cel-
lulose synthase like protein CslA of S. coelicolor 
and the penicillin-binding protein PBP3 of 
M. smegmatis. CslA mainly accumulates at the 
hyphal tips of the S. coelicolor mycelium and 
is involved in the deposition of b-1,4-linked 
polysaccharides at the tips of the hyphae. CslA 
interacts with DiviVA in a bacterial two-hybrid 
assay (Xu et al., J Bacteriol 2008) but evidence 
that polar recruitment of CslA requires DiviVA 
is still lacking. Such analyses are hampered in 
actinobacteria by the severe morphological 
deformations in DiviVA depleted cells which 
make it hard to conclude whether a possible 
protein localization defect is due to the lack of 
DiviVA or caused by alterations of cell shape. 
The interaction between PBP3 and the DiviVA-
homolog Wag31 from mycobacteria was 
shown by a multitude of approaches including 
co-immunoprecipitation, bacterial two-hybrid 
analysis, and surface plasmon resonance 
experiments (Mukherjee et al., Mol Microbiol 
2009). Likewise to the situation in S. coelicolor, 
both PBP3 and Wag31 can be found at the cell 
poles (Datta et al., Mol Microbiol 2006; Nguyen 
et al., J Bacteriol 2007) but the interdepen-
dence of their subcellular localization pat-
terns still has to be addressed experimentally. 
interestingly, Wag31 needs to be in the peri-
plasm to interact with PBP3 since mutations 
in the extracellular transpeptidase domain of 
PBP3 abolished the Wag31-PBP3 interaction. 
Wag31 was indeed detected in the extracyto-
solic fraction of M. smegmatis (Mukherjee et al., 
Mol Microbiol 2009). These findings, however, 
challenge our current view on DiviVA proteins 
that are supposed to be non-secreted cyto-
solic factors. The exciting question as to how a 
cytosolic protein that lacks a signal sequence 
can be transported across the membrane, still 
awaits further clarification.
What the DiviVA proteins from all the men-
tioned species have in common is their unique 
localization to curved membrane regions at 
the cell poles and the division site, as well as 
their conserved domain arrangement. What 
distinguishes them, however, is the physiologi-
cal context they work in and the proteins they 
bind to. Their ability to attach to membranes 
is mediated by a highly conserved N-terminal 
lipid binding domain (LBD) that is believed to 
interact with membranes via the insertion of 
surface exposed hydrophobic amino acid side 
chains into the likewise hydrophobic core of 
the phospholipid bilayer (Lenarcic et al., EMBO 
J 2009; Oliva et al., EMBO J 2010). Via a flexible 
linker of varying length, the LBD is connected 
to an a-helical C-terminal domain (CTD) that is 
rich in coiled coils (Oliva et al., EMBO J 2010). 
Monomers of B. subtilis DiviVA assemble into 
a parallel dimer by means of a coiled coil in 
the LBD and due to the coiled coil regions in 
the CTD. Based on analytical ultracentrifuga-
tion it was concluded that DiviVA forms tet-
ramers in solution (Oliva et al., EMBO J 2010). 
Consistently, crystallographic data revealed 
that formation of the DiviVA tetramer arises 
from dimerization of two DiviVA dimers that 
are arranged in an end-to-end orientation. 
it is tempting to speculate that this tetramer 
represents the basic building block of higher 
order DiviVA aggregates since assembly into 
string- and network-like ultrastructures was 
indeed observed in cryo-negative stain trans-
mission electron microscopy experiments 
with a mutant variant (E162K) of B. subtilis 
DiviVA (Stahlberg et al., Mol Microbiol 2004). 
But this mutant protein was described as a 
6- to 8-mer in solution and thus behaved 
different from wild-type DiviVA. All in all, 
however, DiviVA homologs are two-domain 
proteins that consist of an invariant N-terminal 
membrane-binding module fused to variable, 
species-specific CTDs. it therefore appears 
plausible that these regions are important for 
the interaction of DiviVA homologs with their 
species-specific binding partners and it will be 
interesting to determine the structural basis of 
this diversity.
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identifying novel transcription factors required 
for virulence may lead to the identification 
of new drug targets. We have found that 
transcription of a virulence-critical operon of 
Mycobacterium tuberculosis is regulated by a 
novel transcription factor binding far upstream 
of the promoter. This operon includes the espA 
gene, which is required for ESX-1 secretion. 
This system has to be precisely regulated since 
continued secretion of its highly antigenic 
substrates would alert the immune system 
to the infection. Transcription of this operon 
is positively regulated by the EspR transcrip-
tion factor, and dependent upon far-upstream 
sequences containing known EspR binding 
sites. Transcriptional activation therefore takes 
place over long distances of the chromosome, 
by looping out of DNA between the EspR 
binding site and the promoter. EspR thus has 
DNA binding characteristics similar to those of 
nucleoid-associated proteins (NAPs) and joins 
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two other NAP-like proteins, Lsr2 and CRPMt, in 
regulating expression of this operon.
Although virulence in Mycobacterium 
tuberculosis, the causative agent of tuberculo-
sis, is multifactorial, requiring the participation 
of several cell wall and cellular components, 
the ESX-1 secretion system is one component 
that is essential for a successful infection. in 
fact, the genes coding for parts of this secre-
tion system, in the RD1 region, are deleted in 
the attenuated vaccine strain of M. bovis, BCG, 
and restoring the RD1 region to BCG results 
in partial reversal of attenuation. This secre-
tion system, also known as a type Vii system, 
transports certain proteins, notably ESAT-6 
and CFP-10 (also known as EsxA and EsxB) 
into host cells, which appears to affect the 
phagosome membrane, to facilitate dissemi-
nation of M. tuberculosis into the cytoplasm. 
There is also another distinct genetic locus, 
the espACD-Rv3613c-Rv3612c operon, which 
is required for ESX-1 function (and thus espA 
mutants are attenuated in a mouse infec-
tion), and which is expressed in a transient 
manner during infection of the host cell, the 
macrophage. An unusual and notable feature 
of ESX-1 is the mutually dependent nature of 
the secretion, such that the secretion of each 
substrate relies on the secretion of the other 
substrates. Because some of the members 
of the espACD-Rv3613c-Rv3612c operon are 
themselves substrates, then ESX-1 secretion 
could be controlled by the short-lived expres-
sion of this operon that occurs during infec-
tion. Because the ESX-1 secreted proteins are 
antigenic to the adaptive immune system it 
is therefore advantageous to the bacterium 
to switch off the system immediately after 
phagocytosis by the macrophage.
The espACD-Rv3613c-Rv3612c operon is 
thus vital to ESX-1 secretion, and hence to the 
virulence of M. tuberculosis, and clearly precise 
control of its expression is required for a suc-
cessful infection. The chromosomal context 
of this operon is notable in that the upstream 
region is relatively large, there being 1,357 bp 
from the start of the espA open-reading frame 
(ORF) to the start of the divergently transcribed 
Rv3617 ORF, suggesting that there is enough 
DNA to accommodate numerous regulatory 
elements. in fact several DNA binding proteins 
have been shown to regulate expression of 
this operon. Thus it has previously been found 
that the mycobacterial cyclic AMP receptor 
protein (CRPMt) (Rickman et al., Mol Microbiol 
2005) and the nucleoid-associated protein Lsr2 
repress transcription of this operon (Gordon et 
al., Proc Natl Acad Sci U S A 2010), and the 
PhoP (Walters et al., Mol Microbiol 2006; Frigui 
et al., PLoS Pathog 2008) and EspR (Raghavan 
et al., Nature 2008) proteins have been found 
to be likely activators. We first became aware 
that sequences far upstream of the first gene 
in the operon, espA, were affecting transcrip-
tion when we made transcriptional promoter 
fusions. By making a series of such constructs 
with progressively longer fragments of DNA 
upstream of espA, we were surprised to notice 
that there were stepped increases in promoter 
activity as measured by assays for b-galacto-
sidase, the product of the lacZ gene, when 
longer fragments of upstream DNA were fused 
to the reporter gene. Thus, the first 800 bp 
upstream of espA supported relatively low 
expression, but when this was increased to 
include the 800–995 bp region there was a 
six-fold enhancement in expression. We desig-
nated this latter region as the espA Activating 
Region (EAR). More detailed analysis showed 
that the critical region lay between 887 and 
995 bp, with an especially large increase asso-
ciated with the 11 bp between 984 and 995 
bp. Curiously, and perhaps significantly, the 
presence of DNA from 1,100–1,200 bp reduced 
activity to an intermediate level.
We knew that these increases in activity 
were not due to new promoter activity since 
we showed that the only promoter in the 
1,357 bp intergenic region was located 67 bp 
upstream of the espA gene. So the EAR looked 
much like an enhancer, an invertible, mobile 
DNA sequence that increases gene expres-
sion by mediating RNA polymerase assem-
bly at a promoter. Promoter activity could 
be decreased by deletions within the EAR 
(between 993 and 1,003 bp), but it could also 
be decreased by inserting foreign DNA down-
stream of the EAR, suggesting that the EAR 
had been moved too far from the espA pro-
moter at –67 bp. Addition of the EAR to a 520 
bp fragment of the upstream region resulted 
in a sizeable increase in activity, but not if it 
was added to a 217 bp fragment. Moving the 
EAR construct further away in the 217 + EAR 
construct by adding a 661 bp foreign DNA 
fragment did not increase promoter activity, 
showing that the failure of the EAR to act from 
217 bp was not because it was too close and 
unable to loop out. So we concluded that the 
217 bp fragment lacked a further site required 
for the EAR, although it is possible that the 
insert disrupted a genetic element in the 
217 bp fragment. Nevertheless, the EAR was 
not a classical enhancer since inverting it abol-
ished its enhancing effect on transcription.
Our conclusion was that the enhancing 
effect of the EAR could involve the bind-
ing of a protein to this site, but which one? 
As mentioned previously, one of the DNA 
binding proteins previously found to be an 
activator was EspR. To test the likelihood that 
EspR was binding to the EAR we constructed 
an espR deletion mutant of M. tuberculosis 
using homologous recombination, and used 
this as a host for different length espA pro-
moter fusions. From this experiment it was 
evident that the increases in promoter activity 
that resulted from adding longer fragments 
of upstream DNA were dependent upon a 
functional espR gene. We concluded that EspR 
must be mediating the increased transcrip-
tion that resulted from increased length of 
the espA upstream region, thereby enhancing 
promoter activity, by binding far upstream of 
the start of transcription at –67 bp.
Significantly, while we were completing 
these experiments, another group published 
the location of EspR binding sites in the espA 
upstream region (Rosenberg et al., Proc Natl 
Acad Sci U S A 2011). These were reported to 
be at 468 bp, 798 bp and 983 bp upstream of 
the espA gene; the position of the latter two 
high affinity sites correlated very closely with 
the results of our in vivo transcription fusion 
experiments where there was a particularly 
large increase in promoter activity when the 
upstream DNA fragments were extended from 
800 bp to 995 bp. These results therefore pro-
vided a molecular explanation for our in vivo 
transcription activity data. The binding site 
identified was non-palindromic, which would 
explain why the EAR did not function when 
inverted.
As mentioned above, it seemed curious that 
transcription reporter gene activity decreased 
when longer fragments of upstream DNA were 
fused to the lacZ reporter gene. A possible 
explanation of this has now appeared from 
a recent publication by Blasco et al. (PLoS 
Pathog 2012) who have mapped the EspR 
binding sites using ChiP-seq experiments. This 
has shown that there is another major EspR 
binding site between 1,113 bp and 1,214 bp 
upstream of espA: perhaps EspR binding at this 
site has an inhibitory role whereas binding at 
the other sites activates transcription.
interestingly, the DNA upstream of espA 
containing the EspR-binding sites is missing 
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from some members of the M. tuberculosis 
complex. For example, in M. bovis the length 
of DNA upstream of espA is only 465 bp rather 
than the 1,357 bp in M. tuberculosis. This has 
previously been noted as the RD8 deletion. it 
implies that the sequences upstream of –465 
bp relative to the start of the espA gene, are 
not required for virulence since M. bovis is still 
a virulent strain. By examining the sequences 
of many members of the M. tuberculosis com-
plex, it appeared most likely that the common 
ancestor of the members of the M. tuber-
culosis complex had the complete 1,357 bp 
upstream region and this had been reduced 
by two independent deletions, one leading 
to the evolution of certain members of one 
lineage coming mainly from the Philippines 
with an upstream sequences of 288 bp, and 
another resulting in the evolution of strains 
related to M. bovis having a sequence of 
465 bp. We found that the core promoter of 
M. bovis, although having three single nucleo-
tide polymorphisms, had a similar activity to 
the core promoter of M. tuberculosis; never-
theless with the longer upstream region con-
taining the EspR binding sites, transcription 
emanating from the M. tuberculosis sequence 
was approximately three times greater than 
that from the M. bovis sequence. The conse-
quent differences in expression of the ESX-1 
secretion system among these members of 
the M. tuberculosis complex may contribute to 
their differing pathologies.
Studies of the crystal structure of EspR 
reported in the paper by Rosenberg et al., 
mentioned above, and by Blasco et al. (Mol 
Microbiol 2011) have provided intriguing 
evidence of how this protein is binding to 
the upstream DNA sites. These studies have 
shown that EspR contains an N-terminal helix-
turn-helix domain and an atypical C-terminal 
dimerization domain, resulting in a dimer of 
dimers with two subunits binding two con-
secutive major grooves. This means that the 
other two DNA-binding domains can form 
higher order oligomers, enabling EspR to 
bridge distant DNA sites in a cooperative man-
ner, promoting looping of DNA, providing a 
structural explanation for the results of our 
in vivo gene expression experiments; in fact 
Blasco et al. were able to observe such loop-
ing using atomic force microscopy with EspR-
DNA complexes of the 1,357 bp DNA region 
upstream of espA.
All of this evidence demonstrating that 
EspR could influence gene transcription by 
binding at a considerable distance from the 
promoter indicated that EspR was not a con-
ventional transcription factor interacting with 
RNA polymerase at a promoter, but suggested 
it was more similar to a nucleoid-associated 
protein (NAP). These proteins can bind to DNA 
at multiple sites resulting in the bending of 
DNA: they are the functional equivalent of his-
tones in eukaryotes, organizing higher-order 
structures of chromosomes, although they 
do not share structural properties with them. 
Although some, like HU in Escherichia coli, 
bind DNA in a sequence-independent fashion, 
others such as iHF bind to well conserved 
DNA sequences; in this respect EspR appears 
to resemble the latter. NAPs can often also 
influence transcription via multiple possible 
mechanisms, including in some cases displac-
ing an activator, or even interacting with RNA 
polymerase like more conventional transcrip-
tion factors, in other cases by assisting contact 
between regulatory proteins and RNA poly-
merase. in many cases these proteins have 
the ability to introduce bends in the DNA that 
facilitate protein-protein interactions in the 
nucleoprotein complexes.
So how is EspR activating transcription 
from the espA promoter? As previously men-
tioned, we know that espA transcription is 
influenced by at least three other proteins: it 
is activated by another transcription factor 
PhoP, and repressed by CRPMt and possibly by 
the known NAP, Lsr2. One plausible model is 
that the bending of DNA catalyzed by EspR 
facilitates the contact between a transcription 
factor, such as PhoP, and RNA polymerase. in 
the case of CRPMt, we know that it can act as 
a conventional transcription factor at some 
genes in M. tuberculosis by interacting with 
RNA polymerase at sites close to the promoter 
(Stapleton et al., J Biol Chem 2010), but in the 
espA upstream region CRPMt binds at a site over 
1,000 bp away from the transcription start site 
(M. Stapleton, C. Kahramanoglou, unpublished 
data). in E. coli, CRP has also been shown to 
bind to hundreds of sites along the chromo-
some and may have many of the characteris-
tics of NAPs (Grainger et al., Proc Natl Acad Sci 
U S A 2005); based on this paradigm, therefore, 
one possibility is that CRPMt can also act as an 
NAP at some loci such as espA to influence 
gene expression at long range, perhaps in this 
case by displacing EspR.
Also like many other known NAPs, bind-
ing of EspR is not restricted to a single site, 
the espA upstream region. Thus Blasco et al. 
(PLoS Pathog 2012) showed that EspR binds 
to at least 165 genetic loci with binding not 
being restricted to promoter regions. Like 
other NAPs, the levels of EspR in the cell 
are about 30-fold higher than those of clas-
sic transcriptional activators, well in excess 
of that necessary to occupy all of the 582 
experimentally detected (within the 165 loci) 
or the 1,026 computationally predicted bind-
ing sites (Blasco et al., PLoS Pathog 2012). it 
appears to act as an activator of transcription 
of some genes, but as a repressor of others. 
Where it does bind to promoter regions, 
many of the genes concerned have cell wall 
associated functions, including other ESX 
secretion systems, and some have known 
functions in virulence determination, such 
as the fadD26 gene involved in the synthesis 
of the wax-like compound phthiocerol dimy-
cocerosate (PDiM). The reduced virulence of 
espR mutants could therefore be the result 
of multiple defects rather than solely via 
espA and ESX-1 secretion. in this respect it 
resembles CRPMt which also occupies numer-
ous binding sites (C. Kahramanoglou, unpub-
lished data) and affects the expression of 
many genes; similarly the reduced virulence 
of crp mutants could be the result of mul-
tiple defects. Besides espA, some other genes 
regulated by CRPMt, such as fadD26, are also 
regulated by EspR. Moreover, there is a con-
siderable overlap (77%) between the genes 
in the EspR regulon and those controlled by 
the known NAP Lsr2, although as Blasco et 
al. note, the regulatory outcomes are likely 
to be different since the binding mechanism 
of these two proteins differ, with Lsr2 bind-
ing to the minor groove of DNA and EspR 
binding to the major groove. Thus it appears 
that M. tuberculosis has evolved mechanisms 
involving NAPs to coordinately regulate var-
ied sets of genes at distant sites on the 
chromosome.
EspR has previously been reported to 
be secreted by the ESX-1 system (Raghavan 
et al., Nature 2008). This created a negative 
feedback loop that modulated the activity 
of this secretion system. However, the more 
recent study of Blasco et al. (PLoS Pathog 
2012) did not substantiate the claim that 
EspR is a secreted protein. Nevertheless, a 
feedback mechanism does probably regulate 
the levels of EspR, but one based on the 
control of transcription rather than secre-
tion, since Blasco et al. found that EspR 
binds to its own promoter to downregulate 
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its expression, and EspR protein levels are 
growth phase-dependent, reaching a maxi-
mum in stationary phase, at which stage espR 
transcription is lower.
A hallmark of M. tuberculosis infection is the 
ability to form latent infections through the 
formation of granuloma in the lungs. These 
dormant bacteria, which have a low metabolic 
activity, tend to be inaccessible to therapy 
by most antibiotics and form a reservoir of 
infection that can be reactivated especially 
after disturbance of the immune system, 
such as occurs after HiV infection. Since it is 
thought that one-third of the world’s popula-
tion is infected with M. tuberculosis, mostly 
latently, the potential for new tuberculosis 
cases through reactivation of latent infections 
is huge. An interesting prospect therefore is 
that NAPs are involved in the reorganization 
of chromatin and subsequent critical changes 
in gene expression that must occur after the 
reactivation of dormant bacteria. This process 
probably needs to be very closely controlled 
and this would therefore make EspR, Lsr2 and 
CRPMt truly key players in the pathogenesis of 
M. tuberculosis and, as such, potential drug 
targets.
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influenza A viruses activate the host phos-
phoinositide 3-kinase (Pi3K) signaling pathway 
at several stages of their replication cycle, 
which depending upon the stage can have 
pro- or anti-viral consequences. For example, 
transient Pi3K activation due to virion attach-
ment appears to promote virus entry, while 
pathogen recognition receptor-mediated 
Pi3K signaling may contribute to host innate 
immune defenses. in addition, the viral NS1 
protein, a multifunctional virulence factor, 
directly binds and activates Pi3K to enhance 
efficient virus replication. Here, we comment 
on the strain-specific viral requirement for 
NS1-activated Pi3K in vitro and in vivo. Our 
observations with NS1 suggest that to clarify 
the complex interplay between Pi3K signaling 
and viral activators, it is essential to under-
stand the temporal and spatial patterns of 
kinase activation, as well as the specific Pi3K 
subclass and enzyme isotypes involved. it is 
likely that each independent activation event 
regulates individual pathways with distinct 
biological outcomes.
Introduction
The last decade has witnessed a tremen-
dous research effort to identify human 
host cell factors that regulate virus replica-
tion and virulence. Motivated by the need 
to find new antiviral targets for viruses that 
currently cause public health concerns (e.g., 
HiV, hepatitis C and influenza), virologists are 
reporting increasing numbers of virus-host 
protein:protein or protein:nucleic acid interac-
tions, as well as multitudes of host genes and 
pathways that are important for determining 
the outcome of infection. These data have 
largely come from large-scale proteomics (e.g., 
yeast-2-hybrid analyses or affinity purifications 
combined with mass spectrometry), transcrip-
tomics and genome-wide siRNA screens. The 
hope is that by finding ways to manipulate 
these virus-host interactions, novel interven-
tion strategies can be identified. However, the 
sheer amount of data generated, together 
with subtle experimental differences, and 
the intrinsic complexities of cellular signaling 
networks, create a challenge for virologists 
when trying to understand the biological rel-
evance of such findings. One example of this 
in the influenza A virus field is the role of the 
phosphoinositide 3-kinase (Pi3K) pathway, a 
critical signaling checkpoint that regulates 
diverse cellular processes, including growth, 
survival, translation, vesicle trafficking, mem-
brane biology and immunity. Components of 
Pi3K-regulated signaling consistently appear 
as critical factors required for the influenza 
A virus replication cycle in genome-wide 
siRNA screens. Functionally, there is grow-
ing evidence to implicate specific Pi3K path-
ways in the endocytic uptake of influenza 
viruses. Furthermore, several viral products 
have been proposed to directly or indirectly 
modulate the levels of Pi3K activity during 
infection, which confusingly appear to have 
either pro- or anti-viral consequences. in this 
News and Views article, we briefly review the 
complexities of the Pi3K signaling pathway 
and the different ways that influenza viruses 
interact with this important cellular regulator. 
We focus on our recent study regarding direct 
activation of Pi3K signaling by the influenza A 
virus NS1 protein, a multifunctional virulence 
factor. Our data have lead us to hypothesize 
that for NS1-mediated Pi3K signaling to have 
a pro-viral function, activation must occur at 
a distinct sub-cellular location and involve 
a specific Pi3K regulatory isoform. We dis-
cuss the implications of these findings for our 
understanding of all Pi3K signaling events 
during influenza A virus infection. We propose 
that spatial and temporal kinetics intersect 
with isoform-dependent signaling to delineate 
separate biological outcomes for each Pi3K 
activation event.
Class IA PI3K: Signaling Inputs and Outputs
Phosphoinositide 3-kinases (Pi3K) are a fam-
ily of cellular enzymes that phosphorylate 
the 3-hydroxyl group on the inositol ring of 
membrane-embedded phosphatidylinositol 
lipids, thereby generating second messen-
ger molecules that regulate the intracellular 
distribution and activity of various cell signal-
ing proteins. Biological processes regulated in 
this way broadly include cell growth, survival, 
proliferation, intracellular trafficking, cytoskel-
etal rearrangements and migration. Class i 
Pi3K comprises obligate heterodimeric pro-
tein complexes consisting of a catalytic sub-
unit (termed p110) and a regulatory subunit 
(p85-type, p101 or p87), and use phosphati-
dylinositol (4,5) bisphosphate [Ptdins(4,5)P2] as 
their main substrate. Subclass iA Pi3K includes 
those catalytic subunit isotypes (p110a, p110b 
and p110d) that bind the p85-type (p85, p55 
and p50) regulatory subunits. As each of the 
two main p85-type regulatory subunits (p85a 
and p85b) can heterodimerize with any of 
the three p110 catalytic subunits, there are at 
least six types of p85-mediated class iA Pi3K 
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heterodimer. Nevertheless, each heterodi-
mer utilizes the same substrate in the same 
enzymatic reaction to produce the same sec-
ond messenger product. Mechanistically, it is 
unclear how this same reaction output can be 
translated into biologically distinct outcomes, 
but given the conservation of different p85 
and p110 isotypes and data from genetic 
ablation studies in mice, it is obvious that func-
tional output differentiation must exist.
Canonically, in the absence of a stimulus, 
Pi3K p110-p85 heterodimers remain inactive 
in the cytoplasm: the default function of the 
regulatory p85 subunit is to inhibit the cata-
lytic p110 subunit via specific intermolecular 
contacts. Upon various stimulatory signaling 
inputs, including external stimuli such as 
growth factors or cytokines, the inactive com-
plex moves to the plasma membrane, where 
the SH2 domains of p85 dock with phosphoty-
rosine residues present in receptor-associated 
signal-transduction proteins (summarized in 
Fig. 1). This leads to a rearrangement of the 
intermolecular interactions between p85 and 
p110, such that the enzymatic activity of p110 
is no longer inhibited, thereby stimulating 
production of the intracellular second mes-
senger, phosphatidylinositol (3,4,5) trispho-
sphate [Ptdins(3,4,5)P3], from Ptdins(4,5)P2. 
Downstream of Pi3K activation, several effec-
tor proteins that possess pleckstrin homol-
ogy (PH) domains [or other Ptdins(3,4,5)
P3-regulated domains] are recruited to the 
newly generated Ptdins(3,4,5)P3, and nucleate 
a plethora of different signaling cascades.
The Ser/Thr kinase Akt is the best-studied 
PH domain-containing effector downstream of 
Pi3K, and its activating phosphorylation at Ser-
473 following Ptdins(3,4,5)P3 binding has been 
used as a universal cell-based reporter for Pi3K 
activity. However, several other mechanisms 
exist to increase Pi3K versatility. The variety of 
PH domain-containing proteins besides Akt 
greatly expands the range of signals that can 
be propagated from a single second messen-
ger such as Ptdins(3,4,5)P3. As stated above, 
the conservation of different p85 and p110 iso-
types must lead to distinct activities, although 
these are poorly understood. Nevertheless, 
there is some evidence to suggest a p85- 
specific bias in directing the Pi3K heterodi-
mer toward distinct interaction partners, such 
as certain growth factor receptors that have 
been activated by specific ligands. Moreover, 
although Ptdins(3,4,5)P3 is mainly generated 
at the plasma membrane, it can also be found 
on nuclear and endocytic membrane com-
partments. Thus, the intracellular distribution 
of Ptdins(3,4,5)P3 pools could influence effec-
tor protein composition at particular sites, 
thereby differentially regulating functional 
propagation of Pi3K signaling. Furthermore, 
in addition to their lipid kinase activity, several 
p110 subunits have protein kinase activity 
that may be specific to certain cellular sub-
strates, and there have been proposals that 
some p110 subunits have distinct non-cata-
lytic, scaffold-like activities. Direct activation 
of small GTPases (Ras, Rac and Arf super-
families) by Pi3K has also been described. in 
summary, the cellular Pi3K system is a highly 
regulated system that can discriminate inputs 
from a variety of extracellular stimuli and 
convert them into specific functional outputs. 
The multitude of Pi3K isotypes, their intracel-
lular locations and their differential protein/
lipid kinase or non-catalytic activities likely 
contribute to this.
Figure 1. Physiological activation of class iA Pi3K. The p110-p85 heterodimers, cytoplasmic in their basal state, dock to cellular membranes upon acti-
vation of various signal receptors, including receptor tyrosine kinases. A conformational change in p85 relieves the p110 catalytic site from inhibition 
by the p85 SH2 domains, and Ptdins(3,4,5)P3 is generated. Akt (and others with pleckstin homology (PH) domains) bind to Ptdins(3,4,5)P3 and build up 
local signaling platforms for multiple cellular pathways. SH3, Src-homology 3; BH, breakpoint-cluster region homology; nSH2, N-terminal Src-homolo-
gy 2; iSH2, inter-SH2; cSH2, C-terminal Src-homology 2.
www.landesbioscience.com Virulence 413
PI3K Activation during Influenza A Virus 
Infection
influenza A viruses are the etiological agents 
of an acute respiratory disease in humans. 
These viruses cause both seasonal outbreaks 
and occasional pandemics, and remain a major 
global health concern despite our improving 
knowledge on their biology, and the develop-
ment of intervention strategies such as vac-
cination. influenza A viruses encode 10–12 
polypeptides on their 8-segmented, negative-
sense RNA genome. Given this small coding 
capacity, the virus is highly dependent upon, 
and must interact extensively with, various 
host-cell signaling components to influence 
both the viral replication cycle and disease 
outcome. As described below, the Pi3K sig-
naling pathway is an intriguing example of 
this, as influenza A viruses appear to encode 
several factors that stimulate activation of this 
pathway.
initial studies on the effect of influenza 
A virus infection on Pi3K signaling (by moni-
toring Akt Ser-473 phosphorylation levels) 
detected two temporally regulated waves of 
activation. The first wave appears to be weak, 
transient, and occurs very early during infec-
tion (~15–30 min post-infection). Some stud-
ies have proposed that influenza virus particle 
attachment to sialic acid-containing receptors 
on the surface of cells it is entering triggers the 
clustering of receptor tyrosine kinases, thereby 
mimicking canonical activation of class iA Pi3K 
by growth factors. This, in turn, may promote 
endocytosis and contribute to acidification 
of late endosomes by activating v-ATPases, 
a critical step in triggering virus-host mem-
brane fusion and the release of incoming 
viral genomes into target cells. Furthermore, 
Ras-mediated activation of another Pi3K class 
(iB) has also been suggested to potentiate 
clathrin- and Akt-independent endocytosis of 
influenza viruses.
The second wave of Pi3K activation during 
influenza A virus infection occurs at interme-
diate-to-late time points (~4–6 h onwards), 
is characterized by high levels of phosphory-
lated Akt and is mediated by expression of the 
viral NS1 protein, a multifunctional virulence 
factor with well-defined roles in antagonizing 
the host innate immune system. NS1 spe-
cifically and directly binds the p85b regula-
tory subunit of Pi3K, but is unable to bind 
p85a, an intriguing observation for which the 
reasons are unknown. in vitro assays have sub-
sequently indicated that such an interaction 
forms the core of a heterotrimeric complex 
between NS1, p85b and an inhibition-relieved, 
catalytically active p110 (Fig. 2). Structural, 
functional, and biochemical studies have char-
acterized the interacting residues in both NS1 
and p85b. Among them, the highly conserved 
tyrosine at position 89 of NS1 (Y89) is critically 
positioned at the interface between NS1 and 
p85b. Conservative substitution of tyrosine 89 
to phenylalanine (Y89F) abrogates the NS1-
p85b interaction, inhibits Pi3K/Akt activation 
and attenuates virus growth in tissue culture. 
Perhaps unsurprisingly, given the underlying 
complexity of the Pi3K network and its mul-
tiple functional outputs, addressing the bio-
logical relevance of Pi3K activation by NS1 has 
been a challenging question. Early work sug-
gested a link between NS1-mediated Pi3K acti-
vation and a delay in virus-induced apoptosis, 
which is consistent with a clearly established 
anti-apoptotic role for the Pi3K/Akt pathway. 
However, other studies have provided data to 
indicate that even though NS1 has anti-apop-
totic properties, these are independent of Pi3K 
activation, at least in the context of the influ-
enza virus strains tested so far. Another study, 
more focused on tissue-specific activities, indi-
cates that NS1-activated Pi3K can play a role in 
regulating cation currents (and thereby liquid 
accumulation) in the respiratory epithelium of 
the lung. Many factors may account for these 
discrepancies, not least experimental variation 
in the viral strains and cell types used, the NS1 
mutations that abrogated p85b binding, and 
the use of pharmacological inhibitors with 
unknown specificities and off-target effects.
Although NS1 appears to be the main 
activator of Pi3K during influenza A virus infec-
tion, other viral products also stimulate this 
signaling pathway, thereby adding layers of 
complexity. in particular, viral genomic RNA 
(vRNA) may trigger a Pi3K-dependent antiviral 
response leading to production of interferon. 
Such vRNA-stimulated Pi3K signaling seems 
to be mediated by the host viral RNA sensor, 
RiG-i, and should have a biological effect (e.g., 
anti-viral) opposite to that of NS1-activated 
Pi3K (e.g., pro-viral). An unresolved question 
Figure 2. A model of NS1-activated Pi3K. NS1 binds the iSH2 domain of p85b and displaces 
the inhibitory nSH2 domain. The docking of NS1-activated Pi3K complexes to membranes, the 
involvement of effectors other than Akt and the ultimate biological consequences remain unclear. 
Different viral strains and Pi3K isotypes may drive the response through distinct pathways.
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is therefore how absolute activation of Pi3K by 
distinct viral inputs can lead to varying conse-
quences for the virus at different stages of the 
replication cycle.
Strain-Specific Consequences of NS1-
Activated PI3K: Not All PI3K Events are Equal?
Previous studies had shown that introduction 
of the NS1-Y89F mutation into an H3N2 strain 
of influenza virus (A/Udorn/72) abrogates Pi3K 
activation and attenuates virus replication dur-
ing infection of tissue culture cells. We were 
initially interested in assessing the contribu-
tion of NS1-activated Pi3K to influenza virus 
virulence in vivo, something that had not been 
previously assessed. For this purpose, we used 
the well-established mouse model of influenza 
A virus infection and introduced the NS1-
Y89F mutation into two widely used mouse-
lethal H1N1 strains of influenza virus: A/Puerto 
Rico/8/34 (PR8) and A/WSN/33 (WSN). in tissue 
culture, the mutant PR8 virus (rPR8 NS1-Y89F) 
was clearly attenuated as compared with its 
wild-type counterpart. However, there was no 
appreciable difference between the wild-type 
and mutant WSN viruses, despite clear differ-
ential activation of Pi3K. Given the variety and 
cell type-specific activities of Pi3K, we hypoth-
esized that the effect of NS1-activated Pi3K 
could be limited in the homogeneous context 
of tissue culture, but still have a significant 
impact within a complex animal model. Hence, 
it was surprising to find that the phenotypic 
difference between strains was maintained 
in vivo: mice infected with rPR8 NS1-Y89F 
showed less morbidity and mortality that 
those infected with wild-type rPR8, while no 
significant differences were observed between 
the wild-type and mutant WSN viruses. in 
accordance with this, mutant PR8 virus grew 
to lower titers in mouse lungs than wild-type, 
but there was no significant difference in lung 
titers between wild-type WSN and the NS1-
Y89F mutant.
Both PR8 and WSN NS1 proteins are able 
to bind p85b and promote phosphorylation of 
Akt. Furthermore, it is clear that the Y89F muta-
tion abrogates binding and activation of Pi3K 
for both strains. Thus, it was intriguing to find 
that removal of the Pi3K activating phenotype 
from these two strains lead to different func-
tional consequences. interestingly, we found 
a clear difference between PR8 and WSN in 
the intracellular localization of Ptdins(3,4,5)P3 
(the catalytic product of activated Pi3K) after 
co-expression of each NS1 protein with p85b 
and p110a. Cells transfected with PR8 NS1 
showed increased levels of Ptdins(3,4,5)P3 
accumulating in discrete domains of the 
plasma membrane that we have yet to iden-
tify, while WSN NS1-induced Ptdins(3,4,5)P3 
preferentially accumulated in nuclear and peri-
nuclear areas and was not detectably enriched 
at the plasma membrane. From these results, 
we postulated that the subcellular location 
of Pi3K activation defines the functional out-
put. in other words, although the initial play-
ers involved in the process remain the same 
[i.e., NS1, Pi3K, Ptdins(3,4,5)P3 and Akt], the 
pathways they activate downstream (together 
with their respective biological consequences) 
depend on the spatial platform from which 
they are signaling. Thus, we hypothesize that 
the Pi3K signaling cascade initiated at dis-
crete domains of the plasma membrane has 
a different function to that initiated in the 
perinuclear/nuclear regions. Accordingly, the 
PR8 strain is sensitive to defects in activating 
this specific pathway, while the WSN strain 
is not (Fig. 3). Presumably, the WSN strain 
does not require plasma membrane-mediated 
NS1-activated Pi3K for its replication strategy, 
and it is possible that the ability of this NS1 
protein to activate Pi3K is a remnant of viral 
requirement prior to laboratory and mouse 
adaptation. Multiple issues remain to be elu-
cidated, including the molecular mechanism 
behind the strain-specific NS1 behavior (our 
data suggest that NS1 carries the information 
required to drive Pi3K activation to a particular 
location), the identity of different platform-
specific pathways activated and the reason 
for the apparent lack of biological relevance 
for the WSN NS1-induced perinuclear/nuclear 
accumulation of Ptdins(3,4,5)P3. At this point 
we cannot rule out that WSN NS1-activated 
Pi3K may have biological consequences for the 
virus in other experimental systems beyond 
tissue culture cell-lines and murine models.
Widening the Scope beyond Location, 
Location, Location?
We believe that our observations on the strain-
specific spatial activation of Pi3K by NS1 and 
the assumed different signaling and biologi-
cal consequences this has on virus replica-
tion are applicable to our understanding of 
other Pi3K signaling events during influenza 
virus infection. Thus, future studies on Pi3K 
activation should address spatial distribution 
during infection and focus on specific subcel-
lular events rather than broad global report-
ers such as total Akt phosphorylation. in this 
way, we may begin to resolve the functional 
consequences of Pi3K activity downstream 
of such diverse stimuli as virion binding, NS1 
and vRNA-mediated activation of RiG-i. it may 
be that the other activation events also have 
strain-specific outcomes that need to be con-
sidered, and it will certainly be important to 
identify the kinetics of activation with each 
stimulus and combine this with the spatial 
Figure 3. Strain-specific localization of Pi3K activation. Viral strain specificity of Ptdins(3,4,5)P3 
generation patterns by NS1-activated p110a-p85b complexes and their correlation with virus 
performance profiles in vitro and in vivo.
www.landesbioscience.com Virulence 415
data. For example, given that NS1 location 
varies over the course of infection, different 
NS1-Pi3K signaling foci could be activated suc-
cessively by the NS1 protein of a single viral 
strain, with each focus leading to a different 
biological outcome.
Another critical parameter that has yet 
to be taken into account regarding influ-
enza A virus-mediated Pi3K activation is the 
actual variety that exists within the generic 
term “Pi3K.” An increasingly important area 
of research in the Pi3K field is therefore to 
understand the different roles of various Pi3K 
isotypes. in this regard, the functional conse-
quences of NS1 specificity toward activating 
Pi3K complexes that contain p85b, but not 
p85a, are not understood. Whether there is 
preferential, parallel, redundant or synergis-
tic activation of the different catalytic p110 
subunits by NS1 is also a pertinent question, 
especially given the tissue and cell specificity 
of these isotypes and the array of different cell 
types that influenza A viruses can infect in a 
host organism. This gap needs to be addressed 
not only for NS1, but also for the other viral 
activators of Pi3K. Due to their clinical rel-
evance in cancer and chronic inflammation, 
much effort has been put into developing bet-
ter Pi3K (usually p110) isotype-specific inhibi-
tors and antibodies, many of which are now 
commercially available. Their use may help to 
clarify specific signaling activities and func-
tional phenotypes associated with the diverse 
p110-p85 complexes.
Concluding Remarks
To fully understand how influenza A viruses 
interact with the host Pi3K network, multiple 
variables must be considered. These include 
viral strain, host-cell type, time post-infection, 
subcellular location of the activation events 
and the Pi3K isotypes involved. The conse-
quences of successfully portraying a clear 
picture of this virus-host interaction could 
reach far beyond the virology field, given the 
relevance of Pi3K for almost all physiological 
and pathological processes from development 
to oncogenesis. As viruses have been “learn-
ing” the intracellular molecular biology of our 
cells for a lot longer than academic biologists, 
the nuances and specificities of viral proteins 
such as the influenza A virus NS1 protein may 
become invaluable tools with which to probe 
cell signaling pathways.
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Unlike the situation for many fungal patho-
gens, i.e., those of most plants and animals, 
where efforts at understanding the patho-
genic process are aimed toward controlling 
the disease-causing agent, research on ento-
mopathogenic fungi seeks to develop new 
strategies for improving the ability of the fun-
gus to target its insect hosts. Previous work has 
shown that fungal virulence can be increased 
via overexpression of insect cuticle-degrading 
enzymes, e.g., proteases and chitinases, and 
by expression of insect toxins derived from 
various organisms. A new approach in which 
insect derived molecules are used against 
the insects themselves within the context of 
the microbial pathogenic process has recently 
been described. Depending upon the host 
and molecule chosen it is theorized that target 
specific enhancement of virulence is achiev-
able, a critical step in developing safer and 
more effective biopesticides. Exploiting host 
molecules also places a higher burden on 
potential resistance development as com-
pared with use of chemical pesticides and/or 
insect toxins.
As an alternative to chemical pesticides, 
entomopathogenic fungi have long been 
considered as potential candidates for insect 
pest control. The history of this research and 
any of its applications appears to have under-
gone periodic cycles of alternating intense 
and waning interest. in part, these cycles have 
been as a result of the development and intro-
duction of cheaper and more effective chemi-
cal pesticides and the often less than satisfying 
performance of the fungal microbial agents in 
the field. The current status of the field appears 
to be one of cautious renewal of interest. 
The economic and industrial aspects of these 
efforts will not be considered here, but have 
been recently reviewed (Glare et al., Trends 
Biotechnol 2012). The major impetus driving 
this interest is the gradual banning of the use 
of chemical pesticides coupled to the lack of 
few new such chemicals in the near-term use 
and/or developmental stage. The two most 
widely studied entomopathogenic fungi are 
Metarhizium anisopliae and Beauveria bassi-
ana, both Environmental Protection Agency 
(EPA, US, as well as by the respective EU 
regulatory agency)-approved insect biological 
control agents. Both organisms are currently 
used in various field applications and are avail-
able from a number of commercial sources 
worldwide. However, while there are several 
notable instances of their successful use, a 
number of factors continue to limit practical 
field applications of mycoinsecticides. These 
include relatively low resistance to abiotic fac-
tors that can affect field use, i.e., low tolerance 
to high (> 37°C) and/or fluctuating tempera-
tures, reduced efficacy at low humidity and 
low resistance to sunlight-derived UV irradia-
tion. in addition, issues concerning the length 
of time to kill target insects remain since it can 
take from 3 to 15 d for the fungus to kill its 
insect targets. Finally, the need for high spore 
concentrations for effective suppression of tar-
get insect populations and (low) persistence 
issues place significant constraints on the abil-
ity to use spores and/or other fungal infec-
tious propagules to cover large topographical 
areas, e.g., agricultural fields, in a cost-effective 
manner.
Recombinant DNA techniques have 
afforded an opportunity for strain improve-
ment currently impossible. Attempts at tar-
geted strain isolation and/or selection, 
parasexual crossing or protoplast fusion 
have resulted in only incremental increases 
in virulence and/or a desired trait. Genetic 
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engineering via addition of genes whether for 
pathogenicity determinants, stress resistance 
or some other factor that could increase the 
applicability of the fungal agents represents 
the most versatile approach at strain manipu-
lation. The first such application targeted the 
(over) expression of an endogenous fungal 
protease that had been implicated in the deg-
radation of insect cuticle substrates, i.e., facili-
tated the penetration of the host integument 
(St. Leger et al., Proc Natl Acad Sci U S A 1996). 
in this early work, although the median lethal 
concentration (LD50) was unaffected, increased 
expression of the protease (Pr1) decreased 
the survival time (LT50) by ~25%. Since then 
a variety of proteases, chitinases, the latter 
facilitating the degradation of the chitin poly-
mer that constitutes the major carbohydrate 
constituent of the insect cuticle, and protease-
chitinase hybrid proteins have been expressed 
in either M. anisopliae and/or B. bassiana, each 
showing some improvement in targeting of 
insect hosts.
A second, major development in the field 
occurred with the expression of an insect-spe-
cific scorpion neurotoxin in M. anisopliae which 
increased fungal virulence (i.e., decreased the 
LD50) a dramatic 22-fold against the tobacco 
hornworm (Manduca sexta) and 9-fold against 
adult yellow fever mosquitoes (Aedes aegypti) 
(Wang and St. Leger, Nat Biotechnol 2007). 
This strain also resulted in a ~25–30% decrease 
in LT50, thus killing insects faster and with 
fewer spores. Since then a number of other 
insect toxins have been expressed in either 
M. anisopliae or B. bassiana with similar results. 
This approach, however, has not been without 
controversy. Concerns regarding the use of 
strains expressing neurotoxins (even insect-
specific) as well as the nature of the relatively 
non-specific enhancement of virulence that 
could potentially affect non-target or ben-
eficial insects have been raised. More recently, 
the development of transgenic M. anisopliae 
that target the Plasmodium malarial parasite 
has been reported (Fang et al., Science 2011). 
in this approach, rather than increasing the 
virulence of the biological control agent, the 
fungus was engineered to express a single-
chain antibody that agglutinates the sporo-
zoite, thus reducing the parasite load in the 
mosquito and decreasing transmission of the 
disease causing agent. This development may 
be transformative in that it is likely to be the 
best current candidate for approval in field 
trials.
Given this context, we sought to expand 
the toolbox available for increasing the viru-
lence of these fungi within a different con-
ceptual framework. All insects (as well as most 
other organisms) use proteins and peptides to 
regulate critical physiological processes. These 
molecules are often regulated by strict devel-
opmental and tissue-specific mechanisms. We 
reasoned that disruption of the expression 
pattern of specific proteins/peptides via exog-
enous addition of the molecule could result in 
physiological consequences that would make 
the insect more susceptible to attack by micro-
bial pathogens. Given the broad spectrum of 
molecules that would meet this description, 
several criteria were used to guide the selec-
tion of candidate molecules. First, evidence (in 
the literature) that the candidate molecule was 
essential for proper development or critical 
in key physiological and/or immune related 
processes. Second, evidence that the protein/
peptide displayed some form of toxicity when 
administered to the insect. A third criteria, that 
significantly narrowed the field of potential 
candidates was evidence of field tests and/
or agency approval of the molecule for actual 
use against insects. Finally, as targets for these 
efforts, we chose mosquitoes, which represent 
globally important vectors of disease causing 
agents, and fire ants, an invasive pest species 
that results in significant agricultural, ecologi-
cal and hence economic losses, which also 
have important human health-related impacts.
One of the most promising candidates 
identified was the trypsin-modulating oostatic 
factor (TMOF) derived from the mosquito, 
Aedes aegypti (Fig. 1). TMOFs are hexa- and 
deca-peptides that terminate trypsin biosyn-
thesis in the insect gut and are required for 
normal development and ovipositing. TMOF 
circulates in the hemolymph, binding to recep-
tors on the hemolymph side of the gut and 
inhibits trypsin biosynthesis via translational 
control of trypsin mRNA. TMOF resists pro-
teolysis in the gut and can traverse the gut 
epithelium to enter into the hemolymph. Due 
to this property, it was shown that exog-
enous feeding of Aea-TMOF to mosquitoes 
blocks their ability to digest food, bloodmeal 
or otherwise, subsequently resulting in starva-
tion and death in both adults and larvae. A 
TMOF ortholog was also identified from the 
gray flesh fly, Sarcophaga bullata. The two 
TMOF sequences are highly divergent with the 
A. aegypti sequence corresponding to 10 
amino acids: YDPAPPPPPP, and the S. bullata 
TMOF to six amino acids: NPTNLH. TMOFs 
therefore appear to be good candidates 
regarding specificity with minimal non-target 
effects, a key factor with respect to the desire 
Figure 1. Using host molecules to improve the efficacy of fungal biological control agents. Vari-
ous host-derived peptides, including the mosquito (A. aegypti) trypsin modulating oostatic factor 
(TMOF), the Manduca sexta diuretic hormone (MSDH) and the fire ant (S. invicta) b-neuropeptide 
(b-NP) were selected as candidate molecules for expression in a fungal-insect pathogen (B. 
bassiana) in order to determine whether these factors can be used against the insects themselves 
using the fungus as a means of delivering the compound. images courtesy of C. Zettel, L. Buss, 
and Castner (University of Florida, Entomology and Nematology).
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to develop target specific agents. Commercial 
production and use of Aea-TMOF is currently 
under development, however, the most sig-
nificant obstacle to practical application of the 
peptide is the lack of a mechanism by which 
the peptide can be delivered to the mosquito. 
Since B. bassiana is already a pathogen of 
mosquitoes, we hypothesized that expression 
of Aea-TMOF in the fungus would represent an 
approach at delivering the peptide to the tar-
get, while increasing the virulence of the bio-
logical control agent in a host specific manner.
As further proof-of-concept two additional 
insect-derived candidate molecules were 
selected for expression in B. bassiana: the 
tobacco hornworm, Manduca sexta, diuretic 
hormone (MSDH) and the fire ant, Solenopsis 
invicta, b-neuropeptide (b-NP). insect diuretic 
hormones regulate fluid homeostasis and 
MSDH is a member of the corticotropin-releas-
ing factor-related family of peptides. These 
peptides act upon insect Malpighian tubules, 
excretory organs that lie in the abdominal 
cavity and empty into the junction between 
the midgut and hindgut, affecting their secre-
tion of water and solutes. Administration of 
synthetic MSDH to insects results in fluid loss 
through the gut and epidermis, decreased 
feeding, and ultimately leads to the death of 
the organism. b-NP is a member of the pyro-
kinin/pheromone biosynthesis activating neu-
ropeptide (PBAN) family that is characterized 
by the presence of a C-terminal FXPRL-NH2 
sequence. b-NP is often (co-transcribed and) 
co-translated into a larger protein that is 
subsequently post-translationally cleaved to 
yield smaller peptides. These smaller peptides 
can include diapause hormone (DH), three 
peptides termed a, b and -neuropeptides 
and PBAN itself, the latter of which is often 
found between the b- and -neuropeptides. 
All of the peptides contain the C-terminal 
FXPRL-NH2 motif, with the amidation reaction 
representing a subsequent (after cleavage) 
post-translational modification of the pep-
tides. Depending upon the insect species, 
these peptides are thought to function in a 
wide range of physiological processes that 
includes stimulation of pheromone biosynthe-
sis, induction and/or termination of diapause, 
pupariartion, melanization and potentially 
mediation of defense responses. in S. invicta, 
the a-peptide is lacking.
in all, we assessed the impact of expressing 
Aea-TMOF, Sb-TMOF, MSDH and Si-b-NP in the 
fungal insect pathogen B. bassiana (Fan et al., 
Nat Biotechnol 2012; Fan et al., PLoS One 2012). 
Each peptide was independently expressed 
in constructed fungal strains via transforma-
tion using vectors containing a constitutive 
B. bassiana derived gpd promoter and the 
nucleotide sequences of each peptide fused to 
a signal sequence to drive extracellular secre-
tion of the molecule produced. Production of 
the peptides in culture media was confirmed 
by mass spectrometry and the concentrations 
ranged from 0.2 to 1.0 M. Expression of 
MSDH increased the virulence (i.e., decreased 
the lethal dose, LD50) from 5- to 10-fold toward 
Lepidopteran hosts including M. sexta and the 
greater waxmoth, Galleria mellonella, as well 
as toward A. aegypti. in addition, the time to 
death (LT50) decreased by ~25–35% as com-
pared with the wild-type parental strain. These 
data suggest that MSDH would act as a broad 
host-range targeting molecule.
Similarly, expression of Aea-TMOF in 
B. bassiana decreased the LD50 6- to 7-fold and 
decreased the LT50 by ~30% against blood-
fed female mosquitoes. However, Aea-TMOF 
expressing strains were no more effective 
against flesh flies (S. bullata) than the wild-
type parent, and expression of Sb-TMOF did 
not increase virulence toward mosquitoes. 
interestingly, expression of Sb-TMOF also did 
not increase virulence toward S. bullata, sug-
gesting that the physiological requirement 
and/or role of TMOF in the flesh fly may differ 
significantly from that in mosquitoes. in addi-
tion to increasing virulence toward both the 
adult and larval stages of the mosquito, several 
important “side effect” impacts were noted for 
the B. bassiana strain expressing Aea-TMOF. 
As expected, gut trypsin activity was inhib-
ited, but larval development was stunted and 
fecundity was dramatically decreased, with 
female mosquitoes laying ~55% fewer eggs 
than uninfected controls. Since one of the 
major obstacles regarding field use of fungi 
against mosquitoes is that the relative time 
frame it takes to kill the insect would still 
allow for a reproductive cycle, the decreased 
fecundity effect could have a significant 
impact on biological control efforts that seek 
to decrease vector populations and hence 
disease transmission.
Expression of Si-b-NP in B. bassiana 
increased fungal virulence approximately 
6-fold toward fire ants (decreased LD50) and 
decreased the mean survival time (LT50) by 
~30%. in this instance no significant differ-
ences were seen between the wild-type strain 
and the Si-b-NP expressing strain toward the 
Lepidopteran hosts Galleria mellonella and 
Manduca sexta. However, (unexpectedly) alter-
nations in social behavior were noted in ants 
infected with the Si-b-NP expressing strain 
that did not occur during infections using the 
wild-type B. bassiana parental strain. Whereas 
under normal conditions as well as during 
infection by the wild-type B. bassiana strain, 
the fire ants would remove their dead from 
the surrounding areas of their nests, forming 
discrete “bone piles” or “cemeteries,” a phe-
nomenon termed necrophoretic behavior, 
ants infected with Si-b-NP appeared to leave 
their dead conspecifics randomly distributed 
in the assay chambers. Necrophoretic behavior 
along with grooming represent two important 
behavioral adaptations that have limited the 
use of biological control agents in targeting 
fire ants and other social insect pests, since 
these actions help minimize the spread of 
infections throughout a colony. it remains to 
be seen whether the observations made in 
the laboratory would have any real impact in 
the field; however, these results do illustrate 
that insect pest behaviors can potentially be 
modulated in a target specific manner.
Although we have used fungi as the vehicle 
to deliver host molecules to an intended insect 
target, the use of insect derived proteins and 
peptides could potentially be expanded to 
other insect biological control agents such as 
viruses, bacteria and nematodes. There are 
several potential advantages to the approach 
outlined here that although require further 
investigation and verification, should be 
noted. First, appropriate selection of the host 
molecule can lead to target specific increases 
in virulence. Second, additional beneficial (in 
the sense of increasing the impact of the bio-
logical control agent) can be incorporated in 
the design selection, i.e., via selection of mol-
ecules that disrupt fecundity, feeding or other 
processes and/or behaviors. Finally, we theo-
rize that the development of resistance to our 
approach is minimized as the host molecules 
(peptides) selected participate in critical or 
ideally essential processes that are species and 
tissue specific. Contrary to the use of chemical 
pesticides and/or toxins, where often a single 
mutation could result in resistance, mutations 
that might arise and could compensate for the 
dose given by the fungal-expressed product 
during infection would result in severe devel-
opmental defects, particular since the fungus 
remains a pathogen even in the absence of 
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the expressed molecule. We speculate that this 
would represent a steep fitness cost greater 
than the potential development of resistance 
to a pesticide or toxin. Furthermore, multiple 
host molecules and/or combinations with 
other pathogenicity/targeting factors can be 
expressed in the same fungal strain to further 
improve the efficacy and safety of biologically 
based pesticides.
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Highly pathogenic avian influenza viruses 
(HPAiV) cause devastating outbreaks in domes-
tic poultry worldwide. Moreover, they proved 
to be responsible for repeated severe human 
infections with high lethality raising concerns 
about their pandemic potential. HPAiV are 
restricted to the hemagglutinin serotypes H5 
and H7 and evolve from low-pathogenic pre-
cursors. Since the introduction of an artificial 
polybasic HA cleavage site into non H5/H7 HA 
of low-pathogenic strains may result in high-
pathogenic viruses, the emergence of HPAiV 
with novel serotypes is conceivable. However, 
the observed HA serotype restriction in “natu-
ral” HPAiV indicates a unique predisposition of 
the H5/H7 HA for an insertion mutation coding 
for a polybasic hemagglutinin cleavage site.
Highly pathogenic avian influenza viruses 
(HPAiV), formerly known as fowl plague viruses, 
cause devastating losses in domestic poul-
try. Within the past 130 years, more than 30 
outbreaks have been reported worldwide. 
Furthermore, repeated severe HPAiV infections 
in humans with high lethality have raised con-
cerns about adaptation to the human host 
sparking a novel pandemic. An essential step in 
the replication cycle of all influenza A viruses is 
the cleavage of the hemagglutinin (HA) precur-
sor HA0 into the HA1 and HA2 fragments. Only 
the cleaved HA can undergo a conformational 
change in the acidic endosome resulting in 
exposure of the hydrophobic N termini of the 
HA2 fragments (the fusion peptides) to medi-
ate fusion of the virion envelope with the 
endosomal membrane. This proteolytic activa-
tion requires host proteases that recognize 
specific cleavage sites. The common HA cleav-
age site (HACS) contains a monobasic motif 
that is prevalent in all human, mammalian and 
low-pathogenic avian influenza viruses (LPAiV). 
in contrast, all HPAiV carry a polybasic HACS. 
This difference in cleavage motifs leads to the 
recruitment of different host proteases. The 
monobasic HACS is cleaved by tissue-restricted 
proteases such as TMPRSS2, HAT, other trypsin-
like and perhaps yet unidentified proteases, 
whereas the polybasic HACS is processed by 
the ubiquitous proprotein convertase furin and 
related subtilases. This utilization of different 
proteases results in distinct tissue tropisms. 
Whereas LPAiV and human influenza viruses 
are mostly confined to the digestive or respi-
ratory tracts, respectively, the HPAiV display 
a very broad organ tropism affecting several 
organs including the central nervous system, 
often considered the prime cause of death in 
infected birds. Since experimental removal of 
the polybasic HACS invariably resulted in a 
virus with low-pathogenic phenotype, it is con-
sidered the key virulence determinant of HPAiV.
All HPAiV have evolved from low-patho-
genic precursors due to extension of the HACS 
by an insertion mutation of the HA gene. 
Remarkably, different amino acid sequences 
at the HACS indicate independent mutation 
events. For a few HPAiV, the insert was found 
to originate from recombination with viral (NP 
or M gene) or host (ribosomal 28S) RNA, or was 
suggested to result from polymerase slippage; 
however, in most strains, the mechanism for 
insertion mutation has remained unknown.
Beside the polybasic HACS, HPAiV differ 
from LPAiV in that they are restricted to the 
HA serotypes H5 and H7, two of 16 serotypes 
known in avian viruses. Since the reason for 
this serotype restriction is unclear, we aimed 
to distinguish between the compatibility of 
a polybasic cleavage site with H5/H7 HA only 
and a unique predisposition of those two 
serotypes for insertion mutations. Artificial 
introduction of a polybasic HACS into low-
pathogenic strains of HA serotypes H3, H4 
or H9 did not lead to a high-pathogenic 
phenotype, in contrast to an HACS mutant of 
an H6N1 virus. Remarkably, a polybasic cleav-
age site mutant of a low-pathogenic H5N1 
virus did not display high virulence either. 
Reassortants carrying the HA gene from an 
H5 HPAiV with the other seven genes originat-
ing from either the H9 or H5 LPAiV showed 
only temporary non-lethal disease in chicken, 
whereas reassortants with the reciprocal gene 
constellation, i.e., the LPAiV H9 or H5 HA 
with artificial polybasic HACS and the genetic 
background from an HPAiV, were lethal for 
chickens. Therefore, virulence determinants 
of HPAiV exist beyond the essential polybasic 
HACS and reside both in the HA and the other 
gene segments.
To investigate whether HPAiV of other 
serotypes could emerge in the genetic back-
ground of an HPAiV, we introduced a poly-
basic cleavage site into the HA of LPAiV with 
serotypes H1, H2, H3, H4, H6, H8, H10, H11, 
H14 or H15, and rescued HA reassortants after 
co-transfection with the genes from either 
a low-pathogenic H9N2 or high-pathogenic 
H5N1 avian strain. Those recombinants which 
contained the engineered H2, H4, H8 or H14 
genes in the HPAiV background, were lethal 
in chickens and exhibited intravenous patho-
genicity indices of 2.79, 2.37, 2.85 and 2.61, 
respectively, equivalent to naturally occurring 
H5 or H7 HPAiV. Thus, in the presence of a 
polybasic HACS, nonH5/H7 HA can support a 
highly pathogenic phenotype in the appropri-
ate viral background, indicating requirement 
for further adaptation. Hence, the observed 
restriction of natural HPAiV to serotypes H5 
and H7 is likely due to their unique predisposi-
tion for acquisition of a polybasic HACS.
in the light of our finding that HPAiV with 
non-H5/H7 serotypes can be generated experi-
mentally, it is conceivable that HPAiV with novel 
serotypes could emerge in the future. H5N1 
HPAiV have become endemic in several regions 
such as Southeast Asia or Egypt yielding ample 
opportunity for reassortment with an LPAiV to 
evolve into an HPAiV. However, the molecular 
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basis for the emergence of an HPAiV is still not 
clear and may include these three precondi-
tions: the HA has to be prone to acquire a poly-
basic HACS, a lowered optimal pH to trigger 
fusion of the HA has to be achieved, and other 
virulence and host range determinants like 
the NA stalk deletion have to be established. 
Furthermore, it is still uncertain whether such 
additional virulence determinants have to be 
accumulated before or after formation of the 
polybasic HACS. Moreover, in which avian host 
does this process take place? This evolutionary 
step is likely to happen in gallinaceous poultry 
prior to an HPAi outbreak as suggested by pre-
vious observations. For instance, prolonged cir-
culation of low-pathogenic precursor viruses in 
chickens was found for several months before 
the outbreaks in Mexico 1994 and italy 1999. 
Therefore, at least some of the virulence or 
host range determinants might be required 
for virus survival in the chicken flocks prior to 
acquisition of the polybasic HACS by an inser-
tion mutation that occurs at considerable lower 
probabilities than point mutations.
Taken together, the natural formation of 
a polybasic HACS has so far been restricted 
to H5 or H7 LPAiV. This HA serotype restric-
tion observed in authentic HPAiV points to 
a unique predisposition of the H5/H7 HA for 
polybasic HACS formation. Since in presence 
of the required virulence determinants in the 
HA and other genes, the experimental intro-
duction of a polybasic HACS may result in 
high-pathogenic viruses with HA serotypes 
other than H5 or H7, the emergence of HPAiV 
with novel serotypes is conceivable.
